TherapeuticsMD Inc (TXMD) — Capital Reinvestment Ratio

Latest as of March 2024: 712.82x

TherapeuticsMD Inc (TXMD) has a Capital Reinvestment Ratio of 712.82x as of March 2024, meaning it reinvests 713% of its operating cash flow ($11.00K) in capital expenditures ($7.84 Million). Check TXMD goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

712.82x
Capex / Operating Cash Flow

Operating Cash Flow

$11.00K
USD

Capital Expenditures

$7.84 Million
USD

Data as of

Mar 2024
Most recent filing

TherapeuticsMD Inc Capital Reinvestment Ratio (1993–2006)

This chart tracks TherapeuticsMD Inc's Capital Reinvestment Ratio across 11 annual periods. For the full cash flow conversion analysis, see TherapeuticsMD Inc (TXMD) cash conversion ratio.

Annual Capital Reinvestment Ratio for TherapeuticsMD Inc (1993–2006)

Year-by-year Capital Reinvestment Ratio for TherapeuticsMD Inc from 1993 to 2006. See TXMD cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2006 0.18x $329.84K $57.75K ▼ -21.7%
2005 0.22x $412.34K $92.23K ▼ -85.1%
2004 1.50x $207.73K $311.05K ▼ -15.4%
2003 1.77x $140.00K $247.71K ▲ +182.6%
2002 0.63x $100.08K $62.66K ▲ +367.2%
2001 0.13x $161.95K $21.70K ▼ -97.2%
1998 4.74x $44.60K $211.37K ▲ +285.1%
1997 1.23x $77.53K $95.40K ▲ +639.6%
1995 0.17x $63.45K $10.56K ▼ -82.8%
1994 0.97x $72.86K $70.35K ▼ -35.9%
1993 1.51x $59.76K $90.00K
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow